| Cat. No. |
Product Name |
Information |
| PC-45140 |
Oseltamivir phosphate
Influenza NA inhibitor
|
Oseltamivir phosphate (GS-4104, GS4104) is a competitive inhibitor of influenza neuraminidase that prevents new viral particles from being released; an antiviral agent used to treat and prevent influenza A and influenza B. |
| PC-25607 |
Licoflavone B
Influenza inhibitor
|
Licoflavone B is an isoprene flavonoid derived from licorice residue and potent anti-influenza agent, selectively targets the viral RNA-dependent RNA polymerase (RdRp) with IC50 of 9.9 uM, effectively suppressing viral replication, also exerts anti-ulcerative colitis (UC) activity through blocking the MAPK pathway. |
| PC-25338 |
SA-67
Influenza NA inhibitor
|
SA-67 is a small-molecule inhibition of influenza A virus (IAV) entry, specifically targets viral hemagglutinin (HA), inhibits H7N1 pseudovirus with IC50 of 0.04 uM. |
| PC-25217 |
VNT-101
Influenza NP PPI inhibitor
|
VNT-101 (VNT101) is a potent influenza A virus (IAV) inhibitor disrupting of nucleoprotein (NP)-NP protein-protein interaction (PPI), targets nucleoprotein (NP) subunit of the viral RNP replication complex, has cellular EC50 of 5 nM in H1N1 CPE assays. |
| PC-25212 |
Oseltamivir
Influenza NA inhibitor
|
Oseltamivir (GS4104, GS-4104) is an orally active influenza virus neuraminidase inhibitor (NAI), inhibits influenza A/H3N2, A/H1N2, A/H1N1, and B viruses with IC50s of 0.67, 0.9, 1.34 and 13 nM, respectively. |
| PC-25091 |
Sebaloxavir marboxil
Influenza virus inhibitor
|
Sebaloxavir marboxil is a potent inhibitor of influenza cap-dependent endonuclease, inhibits the replication of influenza virus. |
| PC-24923 |
BPR2-D2
Antiviral
|
BPR2-D2 is a small molecule inhibitor against influenza virus with excellent antiviral efficacy for the oseltamivir-resistant virus (EC50= 0.021 to 0.040 uM), may target viral ribonucleoproteins (RNPs) for viral RNA synthesis, also inhibits SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) with IC50 of 4.6 uM. |
| PC-24187 |
Suraxavir marboxil
Infuenza PA Inhibitor
|
Suraxavir marboxil (GP681) is an orally bioavailable antiviral drug inhibiting the polymerase acidic protein (PA) of RNA polymerase of influenza virus, demonstrates nanomolar antiviral activity against both influenza A and B viruses with the average IC50 on the transcriptional activity of 0.6 nM, EC90 of 6.9 ng/mL. |
| PC-22714 |
Compound J1
Hemagglutinin inhibitor
|
Compound J1 is a small molecule compound targeting hemagglutinin (HA), inhibits influenza A virus and exhibits broad-spectrum antiviral activity against SARS-CoV-2, HSV1 and HSV2. |
| PC-22660 |
AV5116
Influenza virus inhibitor
|
AV5116 is a structural analogue of influenza virus endonuclease inhibitor baloxavir, and cap-dependent endonuclease (CEN) inhibitor. |
| PC-22659 |
AV5115
Influenza virus inhibitor
|
AV5115 is a structural analogue of influenza virus endonuclease inhibitor baloxavir, and cap-dependent endonuclease (CEN) inhibitor. |
| PC-20584 |
MBX2546
Influenza virus HA inhibitor
|
MBX2546 is a small molecule inhibitor of influenza virus via targeting influenza hemagglutinin (HA), specifically inhibits HA-mediated viral entry with potent antiviral activity against different influenza virus strains (IC50=0.3-5.9 uM). |
